These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 12176648

  • 1. Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.
    Petz W, Spada M, Bertani A, Lucianctti A, Casagrande F, Guizzetti M, Corno V, Colledan M, Strazzabosco M, Gridelli B.
    Transplant Proc; 2002 Aug; 34(5):1966-7. PubMed ID: 12176648
    [No Abstract] [Full Text] [Related]

  • 2. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.
    Asensio M, Margarit C, Chavez R, Ortega J, Charco R, Iglesias J.
    Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650
    [No Abstract] [Full Text] [Related]

  • 3. Basiliximab reduces acute liver allograft rejection in pediatric patients.
    Strassburg A, Pfister ED, Arning A, Nashan B, Ehrich JH, Melter M.
    Transplant Proc; 2002 Sep; 34(6):2374-5. PubMed ID: 12270443
    [No Abstract] [Full Text] [Related]

  • 4. Basiliximab in the therapy of acute rejection after organ transplantation.
    Chariat MN, Erren M, Chariat M, Deng M, Wolters HH, Dietl KH.
    Transplant Proc; 2001 May; 33(3):2380. PubMed ID: 11377567
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of basiliximab in pediatric renal transplantation.
    García-Meseguer C, Roldán M, Melgosa M, Alonso A, Peña A, Espìnosa L, Navarro M.
    Transplant Proc; 2002 Feb; 34(1):102-3. PubMed ID: 11959206
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients.
    Marino IR, Doria C, Scott VL, Foglieni CS, Lauro A, Piazza T, Cintorino D, Gruttadauria S.
    Transplantation; 2004 Sep 27; 78(6):886-91. PubMed ID: 15385809
    [Abstract] [Full Text] [Related]

  • 7. Experience with basiliximab in pediatric liver graft recipients.
    Ganschow R, Lyons M, Grabhorn E, Venzke A, Broering DC, Rogiers X, Hellwege HH, Burdelski M.
    Transplant Proc; 2001 Sep 27; 33(7-8):3606-7. PubMed ID: 11750532
    [No Abstract] [Full Text] [Related]

  • 8. Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction.
    Garcia CD, Schneider L, Barros VR, Guimarães PC, Garcia VD.
    Transplant Proc; 2002 Nov 27; 34(7):2533-4. PubMed ID: 12431513
    [No Abstract] [Full Text] [Related]

  • 9. Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients.
    Sifontis NM, Benedetti E, Vasquez EM.
    Transplant Proc; 2002 Aug 27; 34(5):1730-2. PubMed ID: 12176554
    [No Abstract] [Full Text] [Related]

  • 10. Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.
    Filipponi F, Callea F, Salizzoni M, Grazi GL, Fassati LR, Rossi M, Risaliti A, Burra P, Agnes S, De Carlis L, Valente U, Ferrara R, Pisati R.
    Transplantation; 2004 Nov 27; 78(10):1488-95. PubMed ID: 15599313
    [Abstract] [Full Text] [Related]

  • 11. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation.
    Gruttadauria S, Vasta F, Mandalà L, Cintorino D, Piazza T, Spada M, Verzaro R, Gridelli B.
    Transplant Proc; 2005 Nov 27; 37(6):2611-3. PubMed ID: 16182762
    [Abstract] [Full Text] [Related]

  • 12. Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year.
    Duzova A, Buyan N, Bakkaloglu M, Dalgic A, Soylemezoglu O, Besbas N, Bakkaloglu A.
    Transplant Proc; 2003 Dec 27; 35(8):2878-80. PubMed ID: 14697926
    [Abstract] [Full Text] [Related]

  • 13. A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
    Gruttadauria S, Cintorino D, Piazza T, Mandala L, Doffria E, Musumeci A, Di Trapani G, Arcadipane A, Scianna G, Spada M, Verzaro R, Volpes R, Vizzini G, Palazzo U, Minervini M, Marsh JW, Marcos A, Gridelli B.
    Transplant Proc; 2006 May 27; 38(4):1106-8. PubMed ID: 16757278
    [Abstract] [Full Text] [Related]

  • 14. The role of basiliximab induction therapy in adult-to-adult living-related transplantation and deceased donor liver transplantation: a comparative retrospective analysis of a single-center series.
    Viganò J, Gruttadauria S, Mandalà L, Petridis I, Cintorino D, Li Petri S, Varotti G, Minervini M, Volpes R, Biondo D, Vizzini G, Marsh WJ, Marcos A, Gridelli B.
    Transplant Proc; 2008 May 27; 40(6):1953-5. PubMed ID: 18675099
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
    Oellerich M, Armstrong VW, Schütz E, Shaw LM.
    Clin Biochem; 1998 Jul 27; 31(5):309-16. PubMed ID: 9721427
    [No Abstract] [Full Text] [Related]

  • 16. Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation.
    Jonas S, Guckelberger O, Bechstein WO, Berg T, Müller AR, Platz KP, Tullius SG, Settmacher U, Steinmüller T, Hopf U, Neuhaus P.
    Transplant Proc; 1998 Aug 27; 30(5):2179-81. PubMed ID: 9723433
    [No Abstract] [Full Text] [Related]

  • 17. Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months.
    Ramirez CB, Doria C, di Francesco F, Iaria M, Kang Y, Marino IR.
    Transplant Proc; 2006 Dec 27; 38(10):3633-5. PubMed ID: 17175352
    [Abstract] [Full Text] [Related]

  • 18. First experience with basiliximab in pediatric liver graft recipients.
    Ganschow R, Broering DC, Stuerenburg I, Rogiers X, Hellwege HH, Burdelski M.
    Pediatr Transplant; 2001 Oct 27; 5(5):353-8. PubMed ID: 11560755
    [Abstract] [Full Text] [Related]

  • 19. Experience with basiliximab in pediatric renal transplantation.
    Vilalta R, Vila A, Nieto J, Espanol T, Caragol I, Callís L.
    Transplant Proc; 2002 Feb 27; 34(1):100-1. PubMed ID: 11959205
    [No Abstract] [Full Text] [Related]

  • 20. Steroid-free liver transplantation in children.
    Reding R, Gras J, Sokal E, Otte JB, Davies HF.
    Lancet; 2003 Dec 20; 362(9401):2068-70. PubMed ID: 14697809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.